APOE and Alzheimer disease: One possible explanation may be that the relatively weak effect of the non-APOE PRSs in AD makes it easier to identify an association between the non-APOE PRSs and plasma p-tau181 in Aβ positives, which constitute a genuine AD group harboring brain amyloidosis.